Overview

Teriparatide Treatment in Patients With Inherited Osteoporosis

Status:
Completed
Trial end date:
2013-11-01
Target enrollment:
0
Participant gender:
All
Summary
The purpose of this study is to analyse efficacy of teriparatide treatment in patients with new forms of inherited low-turnover osteoporosis.
Phase:
Phase 4
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Helsinki University Central Hospital
Collaborator:
Eli Lilly and Company
Treatments:
Teriparatide
Criteria
Inclusion Criteria:

- inherited low-turnover osteoporosis

- lumbar spine or hip BMD T-score ≤ -2.5

- a written informed consent.

Exclusion Criteria:

- age less than 18 years

- generally accepted contraindications for the treatment